Company Filing History:
Years Active: 2023
Title: Innovator Elliot Offman and His Contributions to Pulmonary Health
Introduction
Elliot Offman, an accomplished inventor based in Richmond Hill, CA, has made significant strides in the field of pharmaceuticals. With a focus on innovative drug formulations, Offman has contributed to advancements in treatments for pulmonary infections, emphasizing the importance of targeted therapies in healthcare.
Latest Patents
Offman holds a patent for a unique formulation titled “Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections.” This groundbreaking patent describes a fixed-dose combination drug product designed for oral delivery. The formulation includes a fixed 158.3 mg dose of clarithromycin, a fixed 13.3 mg dose of clofazimine, and a fixed 40.0 mg dose of rifabutin. It is specifically engineered to treat pulmonary complex (MAC) disease, providing critical solutions for patients in need.
Career Highlights
Elliot Offman works at Redhill Biopharma Ltd., where he continues to innovate in the pharmaceutical sector. His commitment to improving treatment protocols has positioned him as a key player in addressing complex pulmonary diseases. The development of effective dosing regimens is a highlight of his career, showcasing his dedication to enhancing patient care.
Collaborations
Throughout his career, Offman has collaborated with esteemed colleagues, including Reza Fathi and Gilead Raday. These professional partnerships have allowed for the cross-pollination of ideas and strategies, further driving innovation in drug development and healthcare solutions.
Conclusion
Elliot Offman's contributions to the field of pharmaceuticals, particularly with his patent for a fixed-dose combination drug, reflect his dedication to advancing medical treatments. His work not only benefits patients suffering from pulmonary infections but also paves the way for future innovations in drug formulations. As a prominent figure in the industry, Offman’s ongoing efforts will undoubtedly continue to make a positive impact in healthcare.